Consumer Durables

FUJIFILM Holdings Corp.

In the news

WWII anniversary, SoftBank results, Jokowi's state of the union Aug 9, 2020
Japan's battery startups take the world beyond lithium ion Aug 3, 2020
US grants $265m for Fujifilm's COVID-19 vaccine project Jul 28, 2020
Fujifilm to supply Novavax with key part of COVID vaccine Jul 25, 2020
Fujifilm partners with India's Dr. Reddy's to sell Avigan overseas Jul 1, 2020

See more articles on FUJIFILM Holdings Corp.

Business Summary

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Healthcare and Materials Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, and instant photo systems. The Healthcare and Materials Solutions segment covers medical system equipment, cosmetics and supplements, pharmaceuticals, biopharmacy manufacturing and development contracts, regenerative medicine products, chemical products, graphic system equipment, inkjet equipment, display materials, recording media, and electronic materials. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, and paper and consumables. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2022	JPY	USD
Revenue	2,525.77B	22,476.75M
Gross Profit	1,033.22B	9,194.61M
Operating income	229,702M	2,044.10M
Income before tax	260,446M	2,317.69M
Net income	211,180M	1,879.28M
EBITDA	362,701M	3,227.66M
Diluted EPS	526.22	4.68
Dividends Per Share	110	0.97
Total Assets	3,955.28B	32,587.27M
Total liabilities	1,430.34B	11,784.47M
Total equity	2,502.65B	20,619.21M
Operating cash flow	323,934M	2,882.67M
	Currency in JPY	Currency in USD

Historical Data

JPY | USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	2,433.36B	2,431.48B	2,315.14B	2,192.51B	2,525.77B
Gross Profit	969,096M	997,516M	954,493M	869,691M	1,033.22B
Operating income	161,316M	216,184M	186,570M	165,473M	229,702M
Income before tax	197,807M	212,762M	173,071M	235,870M	260,446M
Net income	140,694M	138,106M	124,987M	181,205M	211,180M
EBITDA	288,958M	346,116M	309,223M	288,896M	362,701M
Diluted EPS	321.54	325.82	305.21	451.74	526.22
Dividends Per Share	75	80	95	100	110
Total Assets	3,492.94B	3,414.69B	3,321.69B	3,549.20B	3,955.28B
Total liabilities	1,194.23B	1,169.85B	1,327.93B	1,327.04B	1,430.34B
Total equity	2,079.13B	2,036.96B	1,953.25B	2,204.56B	2,502.65B
Operating cash flow	261,152M	249,343M	255,667M	420,861M	323,934M

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	21,955.35M	21,926.11M	21,293.39M	20,672.94M	22,476.75M
Gross Profit	8,743.79M	8,995.16M	8,778.90M	8,200.19M	9,194.61M
Operating income	1,455.49M	1,949.45M	1,715.96M	1,560.22M	2,044.10M
Income before tax	1,784.73M	1,918.59M	1,591.81M	2,223.98M	2,317.69M
Net income	1,269.43M	1,245.38M	1,149.56M	1,708.55M	1,879.28M
EBITDA	2,607.16M	3,121.12M	2,844.06M	2,723.95M	3,227.66M
Diluted EPS	2.90	2.93	2.80	4.25	4.68
Dividends Per Share	0.67	0.72	0.87	0.94	0.97
Total Assets	32,843.81M	30,850.54M	30,769.22M	32,119.48M	32,587.27M
Total liabilities	11,229.27M	10,569.19M	12,300.81M	12,009.46M	11,784.47M
Total equity	19,549.91M	18,403.24M	18,093.20M	19,950.82M	20,619.21M
Operating cash flow	2,356.27M	2,248.46M	2,351.48M	3,968.23M	2,882.67M

Valuation Measures

Mar 2022
PER	14.22
ROA	5.62%
ROE	8.97%
Operating margin	9.09%
Profit margin	8.36%

Key executives

President, CEO & Representative Director: Teiichi Goto
Chief Financial Officer & Director: Masayuki Higuchi
Director, VP & Chief Technology Officer: Takashi Iwasaki
Executive Officer & Accounting Manager: Masaru Yoshizawa
Executive Officer & Manager-Personnel: Yasushi Zama

Shareholders

FUJIFILM Holdings Corp. (22.0%)
Nomura Asset Management Co., Ltd. (4.7%)
Nippon Life Insurance Co. (3.2%)
Daiwa Asset Management Co. Ltd. (2.2%)
Nikko Asset Management Co., Ltd. (2.0%)
The Vanguard Group, Inc. (1.8%)
Sumitomo Mitsui Financial Group, Inc. (1.8%)
BlackRock Fund Advisors (1.4%)
Fidelity Management & Research Co. LLC (1.2%)
MS&AD Insurance Group Holdings, Inc. (1.1%)

Contact Details

Website:http://www.fujifilmholdings.com/ja/
Address: Tokyo Midtown West, 9-7-3 Akasaka, Tokyo, 107-0052, Japan
Phone: +81.3.6271.1111

Related Companies

FUJIFILM Business Innovation Australia Pty Ltd.
Fujifilm UNIGRAPHICA AG
Fujifilm Holdings Restricted Stock Compensation Plan
Fujifilm Sonosite France SARL
Fujifilm Microdevices Co., Ltd.
Fujifilm Colombia SAS
DS Chemport (Australia) Pty Ltd.
Fujifilm Co., Ltd.
FX Global Supply Solutions, Inc.
Fuji Xerox Industry Development (China) Co., Ltd.
FUJIFILM Printing Plate (China) Co., Ltd.
FUJIFILM Electronic Materials Korea Co. Ltd.
Fuji Xerox Eco-Manufacturing (Suzhou) Co., Ltd.
FUJIFILM Printing Plate Co., Ltd.
FUJIFILM Hungary Ltd.
FUJIFILM (Shanghai) Trading Co., Ltd.
PT Modern Foto
Fujitsu General Co, Ltd.
FUJIFILM Sericol India Pvt Ltd.
FUJIFILM Italia SpA
FUJIFILM Hong Kong Ltd.
FUJIFILM Holdings France SAS
Fuji Xerox of Shenzhen Ltd.
Fuji Xerox Industry Development (Shanghai) Co., Ltd.
Fuji Xerox Far East Ltd.
FX Global, Inc.
Salmat Asia Ltd.
Fuji Hunt Photographic Chemicals Pte Ltd.
Fuji Graphic Systems Canada, Inc.
FUJIFILM Corp.

Competitors

Canon Inc.
Eastman Kodak Company
Butterfly Network, Inc. Class A
Sindoh Co., Ltd
Vieworks Co., Ltd
Sonoscape Medical Corp. Class A
Hologic, Inc.
STCUBE, Inc.
Primax Electronics Ltd.
Lucky Film Co., Ltd. Class A
Careray Digital Medical Technology Co. Ltd. Class A
Young Optics Inc.
Mauna Kea Technologies SA Class O
Charles River Laboratories International, Inc.
ENDRA Life Sciences Inc.
Uni-Pixel, Inc.
Hyperfine, Inc. Class A
Iray Technology Co., Ltd Class A
Sectra AB Class B
Celltrion, Inc.
Binex Co., Ltd
BioCardia, Inc.
BioCryst Pharmaceuticals, Inc.
Check-Cap Ltd.
Cocrystal Pharma Inc
Coherus BioSciences, Inc.
Crystal Clear Electronic Material Co., Ltd. Class A
Emergent BioSolutions Inc.
Gamida Cell Ltd.
IDEXX Laboratories, Inc.

Last Updated on 30 Sep, 2022